Ads
related to: drugs approved for prostate cancer treatment options- HCP Access & Support
Explore HCP Support Information and
Coverage Tools For Patients.
- Important Safety Info
Safety Profile & Adverse Reactions
For XTANDI® (enzalutamide).
- Prescribing Information
View Prescribing Information
For XTANDI® (enzalutamide).
- XTANDI® FAQs For HCPs
Explore FAQs for Providers & Better
Prepare Your Patients.
- HCP Access & Support
Search results
Results from the WOW.Com Content Network
Siddiqui says the drug is approved for patients with advanced prostate cancer whose cancer has grown after hormone therapy or chemotherapy. “I describe it to patients as like a nuclear warhead ...
If the cancer has spread beyond the prostate, treatment options change significantly, so most doctors who treat prostate cancer use a variety of nomograms to predict the probability of spread. Treatment by watchful waiting/active surveillance, HIFU, external-beam radiation therapy, brachytherapy, cryosurgery, and surgery are, in general ...
Bicalutamide is used primarily in the treatment of early and advanced prostate cancer. [1] It is approved at a dosage of 50 mg/day as a combination therapy with a gonadotropin-releasing hormone analogue (GnRH analogue) or orchiectomy (that is, surgical or medical castration) in the treatment of stage D2 metastatic prostate cancer (mPC), [2] [3] and as a monotherapy at a dosage of 150 mg/day ...
Androgen deprivation therapy (ADT), also called androgen ablation therapy or androgen suppression therapy, is an antihormone therapy whose main use is in treating prostate cancer. Prostate cancer cells usually require androgen hormones, such as testosterone, to grow. ADT reduces the levels of androgen hormones, with drugs or surgery, to prevent ...
Shortly afterward, sipuleucel-T was added to the compendium of cancer treatments published by the National Comprehensive Cancer Network (NCCN) as a "category 1" (highest recommendation) treatment for HRPC. The NCCN Compendium is used by Medicare and major health care insurance providers to decide whether a treatment should be reimbursed. [14] [15]
Flutamide (Eulexin): Marketed for the treatment of prostate cancer and also used in the treatment of acne, hirsutism, and hyperandrogenism in women. [3] [4] It has also been studied in the treatment of benign prostatic hyperplasia. [6] Now little-used due to high incidence of elevated liver enzymes and hepatotoxicity and the availability of ...
Ads
related to: drugs approved for prostate cancer treatment options